Parvovirus B19 Antibody IgG Test
Understanding Parvovirus B19 and Fifth Disease
Parvovirus B19 is a common viral infection that primarily affects children, causing the characteristic “slapped cheek” rash of Fifth Disease. While often mild in healthy children, parvovirus B19 can pose serious health risks for specific populations, including pregnant women, immunocompromised individuals, and those with blood disorders. The Parvovirus B19 Antibody IgG Test plays a vital role in diagnosing exposure and immunity status, helping healthcare providers make informed clinical decisions.
What Does the Parvovirus B19 Antibody IgG Test Measure?
This specialized diagnostic test detects immunoglobulin G (IgG) antibodies specific to parvovirus B19. IgG antibodies develop several weeks after initial infection and typically remain detectable for life, providing long-term immunity. The test specifically measures:
- Presence of IgG antibodies indicating past infection and immunity
- Immune system response to parvovirus B19 exposure
- Long-term protection against reinfection
- Historical evidence of Fifth Disease infection
Clinical Significance of IgG Detection
When IgG antibodies are detected, it indicates that the individual has been exposed to parvovirus B19 at some point in the past and has developed immunity. This is particularly important for pregnant women and healthcare workers who may be at risk of exposure, as immunity provides protection against reinfection and potential complications.
Who Should Consider Parvovirus B19 Antibody IgG Testing?
Several groups benefit from this important diagnostic assessment:
Pregnant Women
Pregnant women exposed to parvovirus B19 should be tested to determine their immunity status. While infection during pregnancy is usually harmless, it can occasionally cause serious complications for the developing fetus, including hydrops fetalis and miscarriage.
Immunocompromised Individuals
People with weakened immune systems, including those with HIV/AIDS, cancer patients undergoing chemotherapy, or organ transplant recipients, may experience more severe or prolonged parvovirus B19 infections.
Individuals with Blood Disorders
Patients with sickle cell disease, thalassemia, or other hemolytic anemias are at increased risk of developing aplastic crisis when infected with parvovirus B19.
Healthcare Workers and Childcare Providers
Those working in environments with frequent exposure to children should consider testing to determine their immunity status and understand their risk level.
Key Benefits of Parvovirus B19 Antibody IgG Testing
- Accurate Immunity Assessment: Determine your protection status against Fifth Disease
- Pregnancy Safety: Provide crucial information for prenatal care and fetal health monitoring
- Workplace Safety: Help healthcare and education professionals understand their exposure risk
- Chronic Condition Management: Assist in managing parvovirus risks for immunocompromised patients
- Peace of Mind: Gain clarity about your health status and potential risks
- No Special Preparation: Convenient testing with no fasting or special requirements
- Fast Results: Quick turnaround with next-day reporting available
Understanding Your Test Results
Positive IgG Result
A positive IgG result indicates past infection with parvovirus B19 and the development of protective immunity. This means you are protected against reinfection and can safely work with children or in healthcare settings without concern for contracting Fifth Disease.
Negative IgG Result
A negative IgG result suggests no previous exposure to parvovirus B19 and no immunity. If you are in a high-risk group (pregnant, immunocompromised, or work with children), your healthcare provider may recommend additional precautions or monitoring.
Interpreting Results with Clinical Context
Your healthcare provider will interpret your results in the context of your symptoms, exposure history, and overall health status. In some cases, additional testing for IgM antibodies may be recommended to assess recent infection.
Test Details and Pricing
| Test Component | Price (USD) |
|---|---|
| Parvovirus B19 Antibody IgG Test | $100 (Discounted from $162) |
| Regular Price | $162 |
| Discount Price | $100 |
Testing Process Details
- Sample Type: 2 mL (1 mL minimum) serum from 1 SST
- Shipping Requirements: Refrigerated or frozen transport
- Turnaround Time: Sample by Thursday 6 pm, Report Next Day
- Testing Methodology: Enzyme Immunoassay
- Preparation: No special preparation required
Nationwide Testing Availability
We have convenient testing locations across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art facilities ensure accurate, reliable testing with professional medical oversight.
Take Control of Your Health Today
Understanding your parvovirus B19 immunity status is an important step in protecting your health and the health of those around you. Whether you’re planning a pregnancy, work in healthcare or education, or have underlying health conditions, this test provides valuable information for making informed healthcare decisions.
Ready to schedule your Parvovirus B19 Antibody IgG Test? Contact our dedicated healthcare team today to book your appointment or learn more about this important diagnostic assessment.
Call or WhatsApp: +1(267) 388-9828
Our experienced medical professionals are available to answer your questions, discuss your testing needs, and help you schedule your appointment at a location convenient for you. Take the first step toward understanding your parvovirus immunity status and protecting your health.
